FDA Details Stance On Questions From Generics Makers
The U.S. Food and Drug Administration on Tuesday fleshed out its policies on replying to inquiries from generic-drug makers about upcoming approval applications, aiming to clarify its approach as new timelines...To view the full article, register now.
Already a subscriber? Click here to view full article